Back to Trades
MILLER MICHAEL PATRICK
DirectorCIK 0001236514
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 3
- Active
- 2025–2026
Across 6 filings between 2025–2026, MILLER MICHAEL PATRICK, Director, has disclosed $549.7K in transactions — spread across 3 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $97.2K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Jun 15 | PBYI PUMA BIOTECHNOLOGY, INC. | MILLER MICHAEL PATRICK | Director | Grant | $0 |
| May 19 | RIGL RIGEL PHARMACEUTICALS INC | MILLER MICHAEL PATRICK | Insider | Grant | $0 |
| Feb 3 | RIGL RIGEL PHARMACEUTICALS INC | MILLER MICHAEL PATRICK | Insider | Award | $418.3K |
| Feb 3 | RIGL RIGEL PHARMACEUTICALS INC | MILLER MICHAEL PATRICK | Insider | Other | $0 |
| Jan 12 | BTAI BioXcel Therapeutics, Inc. | MILLER MICHAEL PATRICK | Director | Award | $34.2K |
| Nov 13 | PBYI PUMA BIOTECHNOLOGY, INC. | MILLER MICHAEL PATRICK | Director | Sell | $97.2K |
6 filings